CJC-1295 / Ipamorelin Blend

Overview

This blend combines the two most popular GH secretagogues in a single vial for simplified dosing. CJC-1295 (modified GRF 1-29) amplifies GH pulses while Ipamorelin initiates them — together producing synergistic, physiological GH release.

Why a Blend?

• Convenience: One reconstitution, one injection instead of two
• Precise Ratios: Pre-measured combination ensures optimal synergy
• Cost-Effective: Blends are typically more affordable than buying components separately

Key Benefits

• Natural GH Pattern: Maintains pulsatile release without receptor desensitization
• Body Composition: Fat loss + lean muscle gain over time
• Sleep Quality: Deeper, more restorative sleep
• Recovery: Accelerated recovery between training sessions
• Anti-Aging: Improved skin, energy, and vitality

Mechanism of Action

CJC-1295 mimics GHRH to amplify GH pulse amplitude. Ipamorelin selectively activates ghrelin receptors (GHS-R1a) to initiate GH pulses. The combination produces robust GH release without significantly affecting cortisol or prolactin levels.

Components

Research Status

Both components have completed Phase II trials independently. Blend format is based on clinical dosing ratios.

Safety Profile

Well-tolerated. Common: water retention, tingling at injection site, transient fatigue. Rare: headache, dizziness. Avoid if history of cancer.

Related Compounds